Prognostic Value of Circulating Tumoral DNA After the First 6 Months of Treatment in Patients With Waldenström Macroglobulinemia
Clinical trial NCT04893564 · RECRUITING
Trial details
- NCT number
- NCT04893564
- Sponsor
- Centre Hospitalier Universitaire, Amiens
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-16
- Primary completion
- 2027-07-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.